AdaptHealth (AHCO) EPS (Weighted Average and Diluted) (2019 - 2026)

AdaptHealth's EPS (Weighted Average and Diluted) history runs 8 years deep, the most recent figure standing at -$0.12 for Q1 2026.

• In Q1 2026, EPS (Weighted Average and Diluted) fell 140.0% year-over-year to -$0.12; the TTM figure through Mar 2026 stood at -$0.59 (down 203.51% YoY), while the FY2025 annual figure was -$0.52, down 185.25% from the prior year.
• EPS (Weighted Average and Diluted) was -$0.12 for Q1 2026 at AdaptHealth, up from -$0.73 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.34 in Q4 2024 to a low of -$3.43 in Q3 2023.
• Historically, EPS (Weighted Average and Diluted) has averaged -$0.3 across 5 years, with a median of $0.08 in 2022.
• The sharpest annual moves came in 2022 and 2023: EPS (Weighted Average and Diluted) surged 200.0% in 2022, then sank 9600.0% in 2023.
• A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.02 in 2022, then tumbled by 9600.0% to -$1.94 in 2023, then surged by 117.53% to $0.34 in 2024, then tumbled by 314.71% to -$0.73 in 2025, then soared by 83.56% to -$0.12 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at -$0.12 (Q1 2026), -$0.73 (Q4 2025), and $0.16 (Q3 2025), per Business Quant data.